Craig Millian
Chief Executive Officer bei HLS THERAPEUTICS INC.
Vermögen: 64 616 $ am 31.03.2024
Profil
Craig Millian is currently the Chief Executive Officer & Director at HLS Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023.
He was also the Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018.
Before that, he worked as the Vice President-Commercial at Vertex Pharmaceuticals, Inc. Mr. Millian has an undergraduate degree from the University of Pennsylvania and an MBA from New York University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.02.2023 | 900 ( 0,01% ) | 35 316 $ | 31.03.2024 | |
HLS THERAPEUTICS, INC.
0,03% | 16.11.2023 | 10 000 ( 0,03% ) | 29 300 $ | 31.03.2024 |
Aktive Positionen von Craig Millian
| Unternehmen | Position | Beginn |
|---|---|---|
| HLS THERAPEUTICS INC. | Chief Executive Officer | 01.05.2023 |
Ehemalige bekannte Positionen von Craig Millian
| Unternehmen | Position | Ende |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Operating Officer | 14.04.2023 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.12.2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Ausbildung von Craig Millian
| University of Pennsylvania | Undergraduate Degree |
| New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
